Massachusetts Medical Society: Module 3 - Cannabis Products, Modes of Administration, Dosing Considerations and Contraindications

Module 3 - Cannabis Products, Modes of Administration, Dosing Considerations and Contraindications

Cannabis Products, Modes of Administration, Dosing Considerations and Contraindications

Created by Meredith Fisher-Corn, MD and Stephen B. Corn, MD

Editors' Note: Medical marijuana has become an important area of study in healthcare. Doctors and healthcare professionals must understand the medical, legal, and social issues to best respond to their patients' questions and attend to their needs. This content area is not intended to encourage or dissuade the use of medical marijuana, but has been created to provide a balanced portrayal of the research in this area.

The preceding section provided general guidelines for the recommendation of medicinal cannabis and cannabinoid products. The next two syllabi focus on the information typically included in a drug packet insert. This section addresses cannabis products, modes of administration, dosing considerations, contraindications to medicinal cannabis use and drug interactions, while the next section outlines the physiological and cognitive effects of cannabis.

Learning Objectives

After reading this material, a participant will be able to:

  • Describe a variety of cannabis products and discuss the information with patients and colleagues
  • Describe various modes of cannabis administration and discuss the information with patients and colleagues
  • Describe the pharmacologic profile of cannabis for each of the modes of administration and apply the information to clinical practice
  • Describe cannabis vaporizers and apply the information to clinical practice
  • Discuss the dosing of medical cannabis
  • Discuss the absolute and relative contraindications for the use of medical cannabis with patients and colleagues
  • List the enzymes responsible for the metabolism of three phytocannabinoids (CBD, THC and CBN) and apply that information to clinical practice
  • Identify clinically significant drug interactions that may occur with medical cannabis and apply this information to clinical practice


Meredith Fisher-Corn, MD    

Stephen B. Corn, MD      
Founding Editor-in-Chief

Alan Ehrlich, MD
Clinical Associate Professor, University of Massachusetts School of Medicine (UMMS)

Cecilia J. Hillard, PhD
Director of the Neuroscience Research Center, Medical College of Wisconsin

Meredith Fisher-Corn, MD    

Course Fees

Massachusetts Medical Society (MMS) Member: $42.00
Non-MMS Member: $77.00
Allied Health Professionals: $33.60


Text & Graphics

CME Credit

3.50 AMA PRA Category 1 Credit(s)™  

Accreditation Statement for Joint Providership
This activity has been planned and implemented in accordance with the accreditation requirements and
policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint
providership of the Massachusetts Medical Society and The Answer Page, Inc. The 
Massachusetts Medical Society is accredited by the ACCME to provide continuing medical education for 

AMA Credit Designation Statement 
The Massachusetts Medical Society designates this enduring material for a maximum of 3.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for the Massachusetts Board of Registration in Medicine for risk management study.

National Commission on Certification of Physician Assistants (NCCPA).

Physician Assistants may claim 3.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society.

Continuing Education Credit for Pharmacists
The Board of Registration in Pharmacy in Massachusetts, (BOARD), accepts three continuing education types:  ACPE,  AMA PRA Category 1 Credit™ , and continuing education activities approved by any State Board of Pharmacy.  Click here for a list of all state Boards of Pharmacy.

A score of 70% or higher is required to receive  AMA PRA Category 1 Credit(s)™.  

Activity Term

Original Release Date: June 15, 2017
Review Date: N/A
Termination Date: June 15, 2020

System requirements:

Windows, XP, Vista, 7, 8 
Mac OSX 10.6 higher 
Most modern browsers including: 
Firefox 18.0+ 
Chrome 26+ 
Safari 5+ 
Flash player is required for some Online CME courses.

iOS devices beginning with OS version 5 or higher (includes, iPhone, ipad and iTouch devices) 
Android devices including tablets and phones. 
Windows RT and tablets on Windows 8 are also supported.


Copyright © 2018. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411

(781) 893-4610 | (781) 893-3800 | Member Information Hotline: (800) 322-2303 x7311